Trials / Completed
CompletedNCT05722106
Improving Adherence to COVID-19 Prevention Behaviours: Test of Persuasive Messages
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3,746 (actual)
- Sponsor
- University of Calgary · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this randomized online experiment was to test the effectiveness of using various persuasive appeals (deontological moral frame, empathy, identifiable victim, goal proximity, and reciprocity) at improving intentions to adhere to prevention behaviors. Participants indicated their intentions to follow public health guidelines, saw one of six flyers featuring a persuasive appeal or no appeal, then rated their intentions a second time. Known correlates of attitudes toward public health measures were also measured.
Detailed description
Adherence to non-pharmaceutical interventions (NPIs) for COVID-19, including physical distancing, masking, staying home while sick, and avoiding crowded indoor spaces remain critical for limiting the spread of COVID-19. This study tests the effectiveness of using various persuasive appeals (deontological moral frame, empathy, identifiable victim, goal proximity, and reciprocity) at improving intentions to adhere to prevention behaviors. A randomized online experiment using a representative sample of adult Canadian residents with respect to age, ethnicity, and province of residence was conducted between March 3-6, 2021. Participants indicated their intentions to follow public health guidelines, saw one of six flyers featuring a persuasive appeal or no appeal, then rated their intentions a second time. Known correlates of attitudes toward public health measures were also measured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Persuasive Appeal | Persuasive appeals were manipulated using promotional flyers ostensibly distributed by the Public Health Agency of Canada. |
Timeline
- Start date
- 2021-03-03
- Primary completion
- 2021-03-06
- Completion
- 2021-03-06
- First posted
- 2023-02-10
- Last updated
- 2023-02-10
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05722106. Inclusion in this directory is not an endorsement.